Mangold Insight publishes initial analysis of Brighter
Brighter AB (publ) ("Brighter" or "the Company") announces today that Mangold Insight will begin monitoring Brighter and publishes an initial analysis. The analysis is based on the size of the global diabetes market, which is growing by 6.1 percent per year (CAGR), and the Company's focus on digital diabetes care, where the technology developed by the Company is aiming to improve efficiency within diabetes treatment. Identified challenges are that the Company must succeed with the commercialization in 2022 and thereby establish itself and gain market shares. Mangold Insight believes